Search

Eric W. Thomas

Examiner (ID: 13097, Phone: (571)272-1985 , Office: P/2848 )

Most Active Art Unit
2848
Art Unit(s)
2831, 2848, 2835
Total Applications
2348
Issued Applications
1918
Pending Applications
165
Abandoned Applications
302

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 4954880 [patent_doc_number] => 20080187904 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-07 [patent_title] => 'METAL CHELATE-LABELLED PEPETIDES' [patent_app_type] => utility [patent_app_number] => 12/026740 [patent_app_country] => US [patent_app_date] => 2008-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5967 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0187/20080187904.pdf [firstpage_image] =>[orig_patent_app_number] => 12026740 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/026740
METAL CHELATE-LABELLED PEPETIDES Feb 5, 2008 Abandoned
Array ( [id] => 6368111 [patent_doc_number] => 20100074904 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-25 [patent_title] => 'SPECIFIC ACTIVATION OF A REGULATORY T CELL AND ITS USE FOR TREATMENT OF ASTHMA, ALLERGIC DISEASE, AUTOIMMUNE DISEASE, GRAFT REJECTION AND FOR TOLERANCE INDUCTION' [patent_app_type] => utility [patent_app_number] => 12/525142 [patent_app_country] => US [patent_app_date] => 2008-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 17360 [patent_no_of_claims] => 79 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0074/20100074904.pdf [firstpage_image] =>[orig_patent_app_number] => 12525142 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/525142
Screening method for the identification of agents capable of activating CD4+CD25+ regulatory T-cells through interactions with the HIV-1 GP120 binding site on CD4 Jan 29, 2008 Issued
Array ( [id] => 8642083 [patent_doc_number] => 08367061 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-02-05 [patent_title] => 'Anti-idiotype monoclonal antibodies mimicking the HIV gp120 CD4-binding (CD4bs)' [patent_app_type] => utility [patent_app_number] => 12/524816 [patent_app_country] => US [patent_app_date] => 2008-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 11280 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12524816 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/524816
Anti-idiotype monoclonal antibodies mimicking the HIV gp120 CD4-binding (CD4bs) Jan 28, 2008 Issued
Array ( [id] => 4845505 [patent_doc_number] => 20080181913 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-31 [patent_title] => 'Sugar immunogens' [patent_app_type] => utility [patent_app_number] => 12/010654 [patent_app_country] => US [patent_app_date] => 2008-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6104 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0181/20080181913.pdf [firstpage_image] =>[orig_patent_app_number] => 12010654 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/010654
Sugar immunogens Jan 27, 2008 Abandoned
Array ( [id] => 4807482 [patent_doc_number] => 20080171060 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-17 [patent_title] => 'Modulation of immune response and methods based thereon' [patent_app_type] => utility [patent_app_number] => 12/011581 [patent_app_country] => US [patent_app_date] => 2008-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13228 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20080171060.pdf [firstpage_image] =>[orig_patent_app_number] => 12011581 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/011581
Modulation of immune response and methods based thereon Jan 27, 2008 Abandoned
Array ( [id] => 6592501 [patent_doc_number] => 20100048407 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-25 [patent_title] => 'METHOD FOR DETECTION OF HUMAN IMMUNODEFICIENCY VIRUS' [patent_app_type] => utility [patent_app_number] => 12/522838 [patent_app_country] => US [patent_app_date] => 2008-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3283 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20100048407.pdf [firstpage_image] =>[orig_patent_app_number] => 12522838 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/522838
METHOD FOR DETECTION OF HUMAN IMMUNODEFICIENCY VIRUS Jan 16, 2008 Abandoned
Array ( [id] => 6637406 [patent_doc_number] => 20100173861 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-08 [patent_title] => 'COMBINATIONAL PARADIGM COMBATING HIV, HIV/HSV, OR HIV/HPV INFECTIONS IN HUMANS USING SMALL MOLECULAR WEIGHT COMPOUNDS FROM PLANTS' [patent_app_type] => utility [patent_app_number] => 12/523513 [patent_app_country] => US [patent_app_date] => 2008-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 10094 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0173/20100173861.pdf [firstpage_image] =>[orig_patent_app_number] => 12523513 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/523513
Synergistic antiviral compositions comprising a viral attachment inhibitor, integration inhibitor, and proviral transcription inhibitor Jan 15, 2008 Issued
Array ( [id] => 5992568 [patent_doc_number] => 20110014221 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-20 [patent_title] => 'HIV COMBINATION VACCINE AND PRIME BOOST' [patent_app_type] => utility [patent_app_number] => 12/522848 [patent_app_country] => US [patent_app_date] => 2008-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 16025 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20110014221.pdf [firstpage_image] =>[orig_patent_app_number] => 12522848 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/522848
HIV COMBINATION VACCINE AND PRIME BOOST Jan 10, 2008 Abandoned
Array ( [id] => 6228884 [patent_doc_number] => 20100183622 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-22 [patent_title] => 'VPR FUNCTION AND ACTIVITY' [patent_app_type] => utility [patent_app_number] => 11/971792 [patent_app_country] => US [patent_app_date] => 2008-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31677 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20100183622.pdf [firstpage_image] =>[orig_patent_app_number] => 11971792 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/971792
VPR FUNCTION AND ACTIVITY Jan 8, 2008 Abandoned
Array ( [id] => 11859231 [patent_doc_number] => 09738905 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-08-22 [patent_title] => 'Vector for expressing NC protein of HIV and method for producing NC protein using the same' [patent_app_type] => utility [patent_app_number] => 12/520147 [patent_app_country] => US [patent_app_date] => 2007-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5663 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12520147 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/520147
Vector for expressing NC protein of HIV and method for producing NC protein using the same Dec 19, 2007 Issued
Array ( [id] => 8571446 [patent_doc_number] => 08338089 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-12-25 [patent_title] => 'Method of inhibiting lentiviral infectivity utilizing zinc chelation to inhibit Vif activity' [patent_app_type] => utility [patent_app_number] => 11/984672 [patent_app_country] => US [patent_app_date] => 2007-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 12 [patent_no_of_words] => 10874 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11984672 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/984672
Method of inhibiting lentiviral infectivity utilizing zinc chelation to inhibit Vif activity Nov 19, 2007 Issued
Array ( [id] => 6340217 [patent_doc_number] => 20100247570 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-30 [patent_title] => 'High Mannose Glycoprotein Epitopes' [patent_app_type] => utility [patent_app_number] => 12/514312 [patent_app_country] => US [patent_app_date] => 2007-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7224 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20100247570.pdf [firstpage_image] =>[orig_patent_app_number] => 12514312 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/514312
High Mannose Glycoprotein Epitopes Nov 12, 2007 Abandoned
Array ( [id] => 4892975 [patent_doc_number] => 20080102073 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-01 [patent_title] => 'Antigen-Antibody Complexes as HIV-1 Vaccines' [patent_app_type] => utility [patent_app_number] => 11/929015 [patent_app_country] => US [patent_app_date] => 2007-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10154 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0102/20080102073.pdf [firstpage_image] =>[orig_patent_app_number] => 11929015 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/929015
Antigen-Antibody Complexes as HIV-1 Vaccines Oct 29, 2007 Abandoned
Array ( [id] => 6080126 [patent_doc_number] => 20110142847 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-16 [patent_title] => 'Methods of Eliciting Broadly Neutralizing Antibodies Targeting HIV-1 GP41' [patent_app_type] => utility [patent_app_number] => 11/928612 [patent_app_country] => US [patent_app_date] => 2007-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 15067 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20110142847.pdf [firstpage_image] =>[orig_patent_app_number] => 11928612 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/928612
Methods of Eliciting Broadly Neutralizing Antibodies Targeting HIV-1 GP41 Oct 29, 2007 Abandoned
Array ( [id] => 5368572 [patent_doc_number] => 20090306131 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-10 [patent_title] => 'CELL LINES WITH LATENT IMMUNODEFICIENCY VIRUS AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 11/927262 [patent_app_country] => US [patent_app_date] => 2007-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 17414 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0306/20090306131.pdf [firstpage_image] =>[orig_patent_app_number] => 11927262 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/927262
CELL LINES WITH LATENT IMMUNODEFICIENCY VIRUS AND METHODS OF USE THEREOF Oct 28, 2007 Abandoned
Array ( [id] => 4765582 [patent_doc_number] => 20080176794 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-24 [patent_title] => 'LONG LASTING FUSION PEPTIDE INHIBITORS OF VIRAL INFECTION' [patent_app_type] => utility [patent_app_number] => 11/877300 [patent_app_country] => US [patent_app_date] => 2007-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30226 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20080176794.pdf [firstpage_image] =>[orig_patent_app_number] => 11877300 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/877300
LONG LASTING FUSION PEPTIDE INHIBITORS OF VIRAL INFECTION Oct 22, 2007 Abandoned
Array ( [id] => 4872749 [patent_doc_number] => 20080199483 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-21 [patent_title] => 'LONG LASTING FUSION PEPTIDE INHIBITORS OF VIRAL INFECTION' [patent_app_type] => utility [patent_app_number] => 11/877221 [patent_app_country] => US [patent_app_date] => 2007-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30221 [patent_no_of_claims] => 90 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0199/20080199483.pdf [firstpage_image] =>[orig_patent_app_number] => 11877221 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/877221
LONG LASTING FUSION PEPTIDE INHIBITORS OF VIRAL INFECTION Oct 22, 2007 Abandoned
Array ( [id] => 4892987 [patent_doc_number] => 20080102085 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-01 [patent_title] => 'VACCINE COMPRISING GP120 AND NEF AND/OR TAT FOR THE IMMUNIZATION AGAINST HIV' [patent_app_type] => utility [patent_app_number] => 11/874552 [patent_app_country] => US [patent_app_date] => 2007-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 18389 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0102/20080102085.pdf [firstpage_image] =>[orig_patent_app_number] => 11874552 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/874552
VACCINE COMPRISING GP120 AND NEF AND/OR TAT FOR THE IMMUNIZATION AGAINST HIV Oct 17, 2007 Abandoned
Array ( [id] => 4517871 [patent_doc_number] => 07939083 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-10 [patent_title] => 'Soluble, stabilized, proteolytically cleaved, trimeric HIV-1 gp140 proteins comprising modifications in the N-terminus of the gp41 ectodomain' [patent_app_type] => utility [patent_app_number] => 12/312016 [patent_app_country] => US [patent_app_date] => 2007-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 27 [patent_no_of_words] => 55312 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/939/07939083.pdf [firstpage_image] =>[orig_patent_app_number] => 12312016 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/312016
Soluble, stabilized, proteolytically cleaved, trimeric HIV-1 gp140 proteins comprising modifications in the N-terminus of the gp41 ectodomain Oct 16, 2007 Issued
Array ( [id] => 7739550 [patent_doc_number] => 08105610 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-31 [patent_title] => 'Method of making novel erythrovirus V9 VP2 capsid polypeptides' [patent_app_type] => utility [patent_app_number] => 11/868380 [patent_app_country] => US [patent_app_date] => 2007-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 9 [patent_no_of_words] => 8354 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/105/08105610.pdf [firstpage_image] =>[orig_patent_app_number] => 11868380 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/868380
Method of making novel erythrovirus V9 VP2 capsid polypeptides Oct 4, 2007 Issued
Menu